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Abstract
The contribution of natural killer T (NKT) cells to the pathogenesis of metabolic abnormalities of obesity is controversial.
While the combined genetic deletion of NKT and CD8
+ T-cells improves glucose tolerance and reduces inflammation,
interpretation of these data have been complicated by the recent observation that the deletion of CD8
+ T-cells alone
reduces obesity-induced inflammation and metabolic dysregulation, leaving the issue of the metabolic effects of NKT cell
depletion unresolved. To address this question, CD1d null mice (CD1d
2/
2), which lack NKT cells but have a full complement
of CD8
+ T-cells, and littermate wild type controls (WT) on a pure C57BL/6J background were exposed to a high fat diet, and
glucose intolerance, insulin resistance, dyslipidemia, inflammation, and obesity were assessed. Food intake (15.564.3 vs
15.361.8 kcal/mouse/day), weight gain (21.861.8 vs 22.861.4 g) and fat mass (18.661.9 vs 19.562.1 g) were similar in
CD1d
2/
2 and WT, respectively. As would be expected from these data, metabolic rate (3.060.1 vs 2.960.2 ml O2/g/h) and
activity (21.664.3 vs 18.562.6 beam breaks/min) were unchanged by NKT cell depletion. Furthermore, the degree of insulin
resistance, glucose intolerance, liver steatosis, and adipose and liver inflammatory marker expression (TNFa, IL-6, IL-10, IFN-c,
MCP-1, MIP1a) induced by high fat feeding in CD1d
2/
2 were not different from WT. We conclude that deletion of NKT cells, in
the absence of alterations in the CD8
+ T-cell population, is insufficient to protect against the development of the metabolic
abnormalities of diet-induced obesity.
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Introduction
Obesity coincides with a state of chronic, low-grade inflamma-
tion that has been implicated in the pathogenesis of insulin
resistance and dyslipidemia. In particular, it has been demon-
strated that macrophages, CD8
+ T-cells and regulatory T cells in
adipose tissue and liver play a role in mediating the detrimental
effects of inflammation on metabolism [1–6]. However, there
continues to be interest in determining the potential role for other
immune cells in altering metabolism. In this regard NKT cells are
a sub-population of lymphocytes that are proposed to serve as a
link between the adaptive and innate immune systems [7–9]. NKT
cells have receptor expression characteristics of NK cells (they are
NK1.1
+) and T-cells (they express a T-cell receptor (TCR)).
Notably, the NKT TCR, rather then being activated by peptide
antigens, is activated by glycolipid antigens through the MHC
class I-like molecule, CD1d [7–9], while an alternative activation
pathway is dependent on cytokine signaling from activated
dendritic cells [8]. Irrespective of the method, activation of
NKT cells results in rapid cytokine production (within hours),
which may be of mixed, TH1o rT H2 dominance depending on the
microenvironment to which the NKT cells are exposed and/or
different functional subsets of NKT cells [9].
The potential role of NKT cells in altering metabolism has
received attention, but the data are inconclusive and somewhat
contradictory. Of relevance to the current study are the
observations that diet-induced obese mice [10,11] and ob/ob mice
[12] have a larger proportion of TH1 polarized liver NKT cells
[10], and that administration of the NKT activator a-Galacto-
sylceramide to DIO mice exacerbates glucose intolerance and
adipose tissue inflammation [13], suggesting that NKT may play a
pathogenic role in the metabolic abnormalities associated with
these models. Conversely, obesity reduces overall NKT cell
numbers in liver [10,12,14], while an agonist of NKT cells,
glucocerebroside [15], or adoptive transfer of NKT cells [16]
improves liver steatosis and glucose tolerance in ob/ob mice,
suggesting a protective effect of NKT cells. Clearly, an approach
that would clarify some of these issues would be to ablate NKT
cells and address the consequences of this manipulation on the
development of metabolic dysregulation in obesity. Indeed, a
recent study [13] demonstrated that mice lacking NKT cells have
reduced adipose tissue inflammation and improved glucose
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diet. However, the animals used in this study were also depleted of
CD8
+ T-cells, a vitally important caveat, since a recent study
demonstrates a role for CD8
+ T-cells in driving obesity-related
inflammation and dysregulated glucose homeostasis [17]. Thus,
the metabolic and inflammatory effects of NKT cell deletion alone
remain unknown. The current study was undertaken to address
this issue. To accomplish this goal, mice lacking CD1d were used.
These animals are depleted of NKT cells but maintain a normal
complement of CD8
+ T-cells [18,19], making it possible to
demarcate the effects of NKT cell deletion alone from the effects
of combined NKT/CD8
+ T-cell deletion.
Materials and Methods
Animal Care and Maintenance
CD1d
2/2 mice on a Balb/c background (C.129S2-Cd1
tm1Gru/J)
were obtained from Jackson Laboratories. Homozygous mutant
mice are deficient in both the Cd1d1 and Cd1d2 genes and as a
result lack the natural killer T subset[18,19]. These mice were
bred with C57Bl/6 mice to obtain N1F1 heterozygotes, which
were subsequently backcrossed to pure C57Bl/6 mice. The gender
of the mice in the backcross was alternated with each generation.
CD1d heterozygotes of at least the N7 generation (.99% Bl/6
background) were mated to obtain CD1d
2/2 and wild type
littermate controls. Prior to experiments, mice were maintained on
a constant 12-h light:12-h dark cycle with free access to water and
ad libitum fed with a standard chow diet. All procedures were
approved by the Institutional Animal Care and Use Committee
(IACUC) of the University of Pittsburgh, and were in accordance
with the National Research Council’s Guide for the Care and Use of
Laboratory Animals.
Experimental Design
CD1d
2/2 and wild type littermate control mice were fed ad
libitum with a standard chow (SC) or high fat (HF) diet (44%
calories from fat – 19% Lard, 1% Corn Oil) from Harlan Teklad
for 26 weeks. Mice and food were weighed weekly over the course
of the experiment. During this period, mice underwent an analysis
of insulin sensitivity using glucose tolerance and insulin tolerance
tests, metabolic rate using the CLAMS (Comprehensive Labora-
tory Animal Monitoring System, OH), and body composition
using a Lunar PIXImus densitometer (Lunar, Madison, WI).
Whole-body scans, with exclusion of the head, were analyzed for
fat and lean masses using the manufacturer’s software. At the end
of this period, blood and tissues were isolated, flash frozen and
stored at 280uC until analysis.
Glucose Tolerance Tests (GTT), Insulin Tolerance Tests
(ITT), and Pyruvate Tolerance Tests (PTT)
For the GTT, 6-hour fasted mice were injected i.p. with 1.5 g/
kg glucose. Blood was sampled from the tail vein every 15 minutes
for 2 hours post-injection and glucose was measured using an
Ascensia Elite glucometer (Bayer, Mishawaka, IN). For the ITT,
non-fasted animals were injected i.p. with 1 unit/kg of human
recombinant insulin (Humulin R, Lilly, Cincinnati, MO). Blood
was sampled from the tail vein every 15 minutes for 2 hours post-
injection and glucose was measured using an Ascensia Elite
glucometer. For the PTT, 6-hour fasted mice were injected i.p.
with 2 g/kg Sodium Pyruvate. Blood was sampled from the tail
vein every 15 minutes for 2 hours post-injection and glucose was
measured using an Ascensia Elite glucometer (Bayer, Mishawaka,
IN).
Flow Cytometry
Cell surface staining was performed in PBS containing 2% FBS
with the following antibodies: anti-CD3-FITC, anti-CD3-PB, anti-
CD69-PE, anti-CD8-PerCP, and anti-NK1.1-PE/Cy7. Stained
cells were analyzed on an LSR II (BD Biosciences) using
FACSDiva software (BD Biosciences).
Tissue and plasma measurements
Liver triglycerides were determined as previously described
[20,21]. Plasma insulin levels were measured using a commercial
kit (by ELISA; ALPCO, Salem, NH) according to the protocol
provided by the manufacturer.
Quantitative reverse transcription-polymerase chain
reaction (qRT-PCR)
For analysis of gene expression, total RNA was isolated from
liver or adipose tissue using TRIzol Reagent (Invitrogen, Carlsbad,
CA) according to the manufacturer’s instructions. RT-PCR was
carried out using gene specific primers, SYBR green master mix
(Bio-Rad, Hercules, CA) and an Applied Biosystems Prism 7300
Real-Time PCR System as previously described [22]. Fold change
in mRNA expression was determined using the DDcT method,
with all genes normalized to b-actin.
Statistical Analysis
Data are expressed as means 6 SE. Statistical significance was
determined by t-test and, where appropriate, analysis of variance
(repeated measures or one-way ANOVA; Bonferroni’s post-hoc
test) was performed using the PASW Statistics program (Chicago,
IL). Statistical significance was assumed at P,0.05.
Results
Early and reversible decrease in liver NKT cells in
response to a high fat diet
Previous studies have reported decreases in liver NKT cells in
response to a high fat diet. We first sought to confirm and extend
these observations, and to assess the effects of diet in other relevant
tissues of C57BL/6J mice. In agreement with previous studies
[10,12,14], there was a selective decrease in the NKT cell
population and the NKT activation marker, CD69 in the liver
(Figure 1A&B) after exposure to a high fat diet. Conversely, the
NKT cell population was enriched in adipose tissue (Figure 1A).
NKT populations were not altered in the spleen or mesenteric
lymph nodes (MLN). To assess the time-course and reversibility of
high fat diet-induced alterations in NKT cells mice were placed on
a high fat diet for 3 weeks, and then a proportion of these mice
were placed back on a standard chow diet for a further 3 weeks. In
response to a 3-week high fat diet, the proportion of NKT cells was
reduced to a similar extent as that observed with a prolonged diet.
Furthermore, reversion to a standard chow diet for 3 weeks was
sufficient to reverse the alterations in NKT cells (Figure 1C).
Additionally, there was no change in NKT cell numbers in the
spleen at 3 weeks of HFD or when subsequently placed on a
standard chow diet for a further 3 weeks (Figure 1D).
NKT depletion does not alter weight gain, food intake,
adiposity, or energy expenditure
The CD1d
2/2 null mouse lacks NKT cells but has a normal
complement of CD8
+ T-cells ([18,19] and Figure 2E). CD1d
2/2
mice and littermate wild-type controls (WT), on a pure C57BL/6J
background, were exposed to a high fat diet, and a number of
metabolic variables were assessed. Weight gain, caloric intake, and
NKT Cells and Obesity
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(Figure 2A–D). Furthermore, indirect calorimetry demonstrated
that metabolic rate and activity were similar in CD1d
2/2 and WT
mice (Figure 3A–C), as would be expected given the lack of an
effect on NKT depletion on body composition and caloric intake.
Insulin sensitivity and glucose tolerance are unaffected
by NKT cell deletion
We next assessed the effects of NKT deletion on obesity-induced
insulin resistance (Figure 4), using insulin (ITT) and glucose tolerance
t e s t s( G T T ) .A sF i g u r e4 ,P a n e l sA & Bs h o w ,t h eG T Ta n dI T T
demonstrate that the degree of insulin resistance in obese CD1d
2/2
mice was similar to obese WT mice. This is also indicated by the area
under the curve for the GTT and ITT (Figure 4C and 4D,
respectively). Fasting blood glucose concentrations were similar
between WT and CD1d
2/2 mice, as were the fasting insulin
concentrations and HOMA values(Figure 5A, B&C).Liver triglyceride
levels were also measured and again, no difference between the groups
was observed (Figure 5D). Finally, Pyruvate Tolerance Test (Figure 5E)
indicated no difference between the two groups.
Deletion of NKT cells does not alter expression of
inflammatory markers
The inflammatory response in obesity is well described and
involves increased expression of TH1 cytokines and macrophage
infiltration/activation into adipose tissue and liver[1,3,4,23,24]. A
previous study[13] demonstrated that the combined deletion of
CD8
+ T-cells and NKT cells reduced adipose tissue inflammation
in obesity. However, the effects of NKT deletion alone are
unknown. Thus, we next assessed the effects of NKT deletion on
the expression of inflammatory markers in WAT and liver of obese
CD1d
2/2 and WT mice. As figure 6 shows, qRT-PCR analysis of
TNFa, IL-6, IL-10, IFN-c, MCP-1 and MIP1a demonstrated that
expression of these genes was similar in CD1d
2/2 and WT
animals. These data, taken with the data presented above
demonstrate that deletion of NKT cells alone is not sufficient to
alter the inflammatory status of obesity.
Discussion
The major goal of this study was to address the contribution of
NKT cells to the development of the metabolic abnormalities of
obesity, motivated by previous reports that have suggested
metabolic and inflammatory effects of altered NKT activity. These
studies have either indirectly inferred roles for NKT cells[10,12,14],
altered the activity/numbers of NKT cells in pre-existing obesity
models[11,13,15,16,25], or have deleted other cell types i.e. CD8
+
T-cells, in addition to NKT cells[13], that have been implicated in
mediating increased inflammation and metabolic dysregulation in
obesity. Importantly, no previous studies have been undertaken in
models with a specific deletion of NKT cells.
To investigate the role of NKT cells in the development of
obesity-related metabolic disturbances in the absence of alterations
in CD8
+ T-cells, we utilized the CD1d knockout mouse line, which
lacks NKT cells, but has a full complement of CD8
+ T-cells, as
opposed to the b2-microglobulin knockout mouse used in a
previous study, which lack both NKT and CD8
+ T-cells[13].
Furthermore, and again unlike study of Ohmura et al.[13], the
current study controlled for the genetic background of the mice by
utilizing wild-type littermates of the C57Bl/6J CD1
2/2 mice. The
Ohmura study demonstrated that deletion of both NKT and
Figure 1. Alterations in tissue NKT-cell composition in the setting of high fat feeding. Wild-type C57Bl/6 mice were placed on a SCD or
HFD for 26 weeks (Panels A and B), 3-weeks (Panel C and D), or 3 weeks followed by a 3-week standard chow diet (Panel C and D). White adipose
tissue (WAT), spleen, mesenteric lymph nodes (MLN, only for the 26 week study) and liver were collected from lean and obese mice, immune cells
were isolated and underwent FACS, as described in Methods. Results are presented as the means6SE for a minimum of 5 animals in each group.
Statistical significance is indicated (*).
doi:10.1371/journal.pone.0019831.g001
NKT Cells and Obesity
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+ T-cells results in an improvement in the glucose intolerance
and inflammation resulting from exposure of the animals to a high
fat diet. The authors conclude that it is unlikely that CD8
+ T-cells
contribute to this phenotype. However, given the more recent
study of Nishimura et al.[17], which demonstrates a role for CD8
+
T-cells in mediating the inflammation and metabolic abnormal-
ities of obesity, and the data obtained in the current study, a more
likely explanation is that much, if not all, of the improvements in
Figure 2. Weight gain and body composition of wild type (WT) and CD1d null (KO) littermate mice on a high fat diet. Weight gain and
caloric intake were assessed in high-fat fed wild-type and CD1d knock out mice, as described in Methods (Panels A–C). All mice underwent dual x-ray
absorbitometry (DXA) as described in Methods (Panel D). CD8
+ T-cells were assessed by FACS (Panel E). Results are presented as the means6SE for a
minimum of 5 animals in each group.
doi:10.1371/journal.pone.0019831.g002
Figure 3. CLAMS analysis. High fat fed wild-type (WT) and CD1d null (KO) mice underwent CLAMS analysis as described in Methods. Data for VO2
(Panels A and B), and ambulatory activity (Panel C) are presented. Results are presented as the means6SE for 4 animals in each group.
doi:10.1371/journal.pone.0019831.g003
NKT Cells and Obesity
PLoS ONE | www.plosone.org 4 June 2011 | Volume 6 | Issue 6 | e19831Figure 4. Glucose and insulin tolerance in wild-type and CD1d null mice. High fat fed wild-type (WT, n=11) and CD1d null (KO, n=9) mice
underwent glucose tolerance tests (GTT) as described in Methods. After 1 week for recovery, all mice underwent insulin tolerance tests (ITT) as
described in Methods. Results are presented as the means6SE.
doi:10.1371/journal.pone.0019831.g004
Figure 5. HOMA, Hepatic Glucose Output and liver triglycerides in wild-type and CD1d null mice. Fasting blood glucose (Panel A, n=11
WT and n=9 KO) and plasma insulin (Panel B, n=7 WT, n=5 KO) concentrations, Pyruvate Tolerance Test (Panel E, n=4 WT and n=4 KO) and liver
triglycerides (Panel D, n=11 WT and n=9 KO) were assessed in WT and KO mice as described in Methods. Results are presented as the means6SE.
doi:10.1371/journal.pone.0019831.g005
NKT Cells and Obesity
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microglobulin null mouse are due to the absence of CD8
+ T-cells.
A number of studies have addressed the effects of obesity on NKT
cell populations and activity[10,11,14] and the effects of interventions
that alter NKT cell activity or number[11,13,
15,16,25] on the metabolic abnormalities of obesity. By putting the
current observations in the context of these studies, it is possible to
conjecture on the various and somewhat contradictory conclusions
reached in these reports. The issue of the contribution of CD8
+ T-
cells to the metabolic phenotype of b2-microglobulin null mouse has
been dealt with above. Turning to the effects of obesity on NKT cell
populations and activity, it is now well established that obesity reduces
liver NKT cellnumbers[10,12,14], and that the remaining NKT cells
are TH1 polarized[14,25]. However, although these studies are
suggestive and are useful for hypothesis generation, by themselves
they do not demonstrate a causative role for NKT cells in
development of the metabolic or inflammatory abnormalities of
obesity. More direct studies have attempted to manipulate the activity
or number of NKT cells in vivo. One approach has been to
administer glycolipids, which are NKT cellagonists, to obese animals
and determine the metabolic consequences of thisintervention. Thus,
Ohmura et al. report that administration of a-Galactosylceramide
(aGC), which is reported to expand the iNKT population[13], to
DIO or ob/ob mice exacerbates adipose tissue inflammation (DIO
and ob/ob) and glucose intolerance (DIO). However, while the effects
ofaGCon inflammatorystatus inthisstudy aresubstantial, the effects
on glucose tolerance are small, although they are statistically
significant. Administration of glucocerebroside (b-Glucosylceramide)
is reported to improve liver steatosis and glucose intolerance in ob/ob
mice[15],althoughtheeffectsofthisglycolipidonNKTcellactivityis
unclear. Unfortunately, NKT cell activity was not assessed in this
study. However, it is possible that these two glycolipids have
differential effects on NKT cell activity or expand different subsets
of NKT cells, although these issues have not been addressed. Finally,
adoptive transfer of NKT cells improves liver steatosis and glucose
tolerance in ob/ob mice [16]. Unfortunately, polarization of the
transferred cells was not assessed in this study, so again we are left to
conjecture that perhaps the beneficial effects are the result of the
specific NKT cell subset used in this study and/or their polarization.
Putting these studies in the context of the current study, we can say
that ablation of NKT cells does not appear to protect against or
contribute to the metabolic abnormalities of obesity. However,
interventions that alter specific NKT populations or their activity in a
pre-existing state of obesity appear to result in alterations in
inflammatory status and metabolic function, the direction of which
may be dependent on the specific NKT population targeted or the
effects of the intervention on NKT polarization.
Two observations worthy of note are the rapidity with which
nutrient composition-induced alterations in the liver NKT cell
population occurs, and the different responses of the liver and
adipose tissue NKT populations in obesity. We demonstrate that
as little as 3 weeks of high fat diet exposure is sufficient to induce
alterations in the liver NKT population. Furthermore, these
changes are rapidly reversed when mice are returned to a low fat
chow diet. Together, these data indicate that the liver microen-
vironment is very sensitive to altered nutrient states, and as for
longer term diets, these changes correlate with hepatic metabolic
and inflammatory alterations, since it is well-established that liver
steatosis and insulin resistance and inflammation are present in
rodent models within a 1–3 week exposure to a high fat diet. We
analyzed multiple tissues of obese C57Bl/6 mice to extend
previous observations of decreases in liver NKT cells. As others
have shown, we observed a decrease in the percentage of NKT
cells in the liver [10,25], however we also found an increase in
NKT cells in the white adipose tissue. As opposed to Miyazaki
et al. [11], but similar to Li et al.[10], we did not see a difference in
the NKT populations in the spleen. In conclusion, the current
study emphasizes the complex relationship between NKT cells
and metabolism and suggests that the simple removal of NKT cells
does not influence metabolic regulation in obesity.
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